These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9810945)

  • 1. Peripherally induced oromandibular dystonia.
    Sankhla C; Lai EC; Jankovic J
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):722-8. PubMed ID: 9810945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK; Jankovic J
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tongue protrusion dystonia: treatment with botulinum toxin.
    Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS
    South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile of various sub-types of writer's cramp.
    Das CP; Prabhakar S; Truong D
    Parkinsonism Relat Disord; 2007 Oct; 13(7):421-4. PubMed ID: 17400019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oromandibular dystonia: a dental approach.
    Maestre-Ferrín L; Burguera JA; Peñarrocha-Diago M; Peñarrocha-Diago M
    Med Oral Patol Oral Cir Bucal; 2010 Jan; 15(1):e25-7. PubMed ID: 19680172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-Onset Focal Task Specific Oromandibular Dystonia in Association with Quran Recitation: A Case Series.
    Al-Hashel JY; Soliman DY; Ismail II
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():3. PubMed ID: 38222897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-onset dystonia.
    Evatt ML; Freeman A; Factor S
    Handb Clin Neurol; 2011; 100():481-511. PubMed ID: 21496604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients.
    Balal M; Demirkiran M
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():3. PubMed ID: 36789171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology, Diagnosis and Management of Oromandibular Dystonia: an Update for Stomatologists.
    Raoofi S; Khorshidi H; Najafi M
    J Dent (Shiraz); 2017 Jun; 18(2):73-81. PubMed ID: 28620630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oromandibular dystonia: from onset to spread a multicenter italian study.
    Trinchillo A; Esposito M; Terranova C; Rizzo V; Fabbrini G; Ferrazzano G; Belvisi D; Erro R; Barone P; Bono F; Di Biasio F; Bentivoglio AR; Lettieri C; Altavista MC; Scaglione CLM; Albanese A; Mascia MM; Muroni A; Pisani A; Berardelli A; Defazio G
    Neurol Sci; 2024 Sep; 45(9):4341-4348. PubMed ID: 38536550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial dystonia: clinical features, prognosis and pharmacology in 31 patients.
    Defazio G; Lamberti P; Lepore V; Livrea P; Ferrari E
    Ital J Neurol Sci; 1989 Dec; 10(6):553-60. PubMed ID: 2515166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.
    Jankovic J; Orman J
    Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.